Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia® and Xgeva®
09/12/2021
Business related Biotechnology Licence-out PARTNER - HIKMA
509 kb 09/12/2021 pdf